Serum type III procollagen peptide: Indicator for pulmonary fibrosis: II. Application in 80 asbestos insulation workers
- 11 January 1987
- journal article
- research article
- Published by Wiley in American Journal of Industrial Medicine
- Vol. 11 (4) , 439-446
- https://doi.org/10.1002/ajim.4700110406
Abstract
An assay for type III procollagen peptide (P‐III‐P) was applied to serum from 80 asbestos insulation workers in order to evaluate its relationship with pulmonary and pleural fibrosis. The serum peptide levels of 16 control workers were 7.8 ± 2.0 ng/ml (mean ± SD). An association between the serum values of P‐III‐P and the profusion of small irregular opacities on chest X‐rays was noted. The levels in the group with moderate interstitial pulmonary fibrosis [profusion category 2 (2/1, 2/2, and 2/3)] and with marked interstitial pulmonary fibrosis [profusion category 3(3/3)] were 9.9 ± 2.3 ng/ml (n = 5) and thus tended to be higher than those of 16 control workers (p<0.1). On the other hand, there was not correlation between serum peptide levels and pleural lesions nor between the former and duration of asbestos exposure. From the results of the investigation [part I of which is reported elsewhere (Okazaki et al, 1986)] this assay may be useful for detecting individuals with a more marked tendency for progression of interstitial pulmonary fibrosis due to asbestos exposure in insulation work.Keywords
This publication has 16 references indexed in Scilit:
- Fibronectin and Procollagen 3 Levels in Bronchoalveolar Lavage of Asbestos-Exposed Human Subjects and SheepChest, 1986
- Two Serum Markers of Collagen Biosynthesis as Possible Indicators of Irreversible Pulmonary Impairment in Farmer’s Lung1–3American Review of Respiratory Disease, 1986
- Variation in serum Type III procollagen peptide with age in healthy subjects and its comparative value in the assessment of disease activity in children and adults with chronic active hepatitis*European Journal of Clinical Investigation, 1985
- Interstitial Lung Diseases of Unknown CauseNew England Journal of Medicine, 1984
- ASBESTOS DISEASE IN UNITED STATES SHIPYARDS*Annals of the New York Academy of Sciences, 1979
- Radioimmunoassay for type III procollagen peptide and its application to human liver diseaseEuropean Journal of Clinical Investigation, 1979
- Computed tomography in pulmonary asbestosisClinical Radiology, 1979
- Biosynthesis of ProcollagenAnnual Review of Biochemistry, 1978
- Open-Lung Biopsy in Diffuse Pulmonary DiseaseNew England Journal of Medicine, 1964